Intervention Review

Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

  1. Colin Chalk1,*,
  2. Tim J Benstead2,
  3. Fraser Moore3

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 17 OCT 2007

Assessed as up-to-date: 21 AUG 2007

DOI: 10.1002/14651858.CD004572.pub2

How to Cite

Chalk C, Benstead TJ, Moore F. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD004572. DOI: 10.1002/14651858.CD004572.pub2.

Author Information

  1. 1

    McGill University, Medicine and Neurology & Neurosurgery, Montreal, Quebec, Canada

  2. 2

    Dalhousie University/Capital Health, Medicine, Halifax, Nova Scotia, Canada

  3. 3

    McGill University, Department of Neurology and Neurosurgery, Montreal, Quebec, Canada

*Colin Chalk, Medicine and Neurology & Neurosurgery, McGill University, Montreal General Hospital - Room L7-313, 1650 Cedar Avenue, Montreal, Quebec, H3G 1A4, Canada. colin.chalk@mcgill.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 OCT 2007

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    E. Bosi, G. Bax, L. Scionti, V. Spallone, S. Tesfaye, P. Valensi, D. Ziegler, Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial, Diabetologia, 2013, 56, 3, 467

    CrossRef

  2. 2
    So-Youn Mok, Sanghyun Lee, Identification of flavonoids and flavonoid rhamnosides from Rhododendron mucronulatum for. albiflorum and their inhibitory activities against aldose reductase, Food Chemistry, 2013, 136, 2, 969

    CrossRef

  3. 3
    Francesco Tecilazich, Thanh L. Dinh, Aristidis Veves, Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome, 2012,

    CrossRef